|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Salani R and Bristow RE: Surgical
management of epithelial ovarian cancer. Clin Obstet Gynecol.
55:75–95. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sokol NS: Small temporal RNAs in animal
development. Curr Opin Genet Dev. 22:368–373. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Contreras J and Rao DS: MicroRNAs in
inflammation and immune responses. Leukemia. 26:404–413. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ruan K, Fang X and Ouyang G: MicroRNAs:
Novel regulators in the hallmarks of human cancer. Cancer Lett.
285:116–126. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reinhart BJ, Slack FJ, Basson M,
Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G:
The 21-nucleotide let-7 RNA regulates developmental timing in
caenorhabditis elegans. Nature. 403:901–906. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Roush S and Slack FJ: The let-7 family of
microRNAs. Trends Cell Biol. 18:505–516. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yan Y, Zhang F, Fan Q, Li X and Zhou K:
Breast cancer-specific TRAIL expression mediated by miRNA response
elements of let-7 and miR-122. Neoplasma. 61:672–679. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tsai CH, Lin LT, Wang CY, Chiu YW, Chou
YT, Chiu SJ, Wang HE, Liu RS, Wu CY, Chan PC, et al:
Over-expression of cofilin-1 suppressed growth and invasion of
cancer cells is associated with up-regulation of let-7 microRNA.
Biochim Biophys Acta. 1852:851–861. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu C, Kelnar K, Vlassov AV, Brown D, Wang
J and Tang DG: Distinct microRNA expression profiles in prostate
cancer stem/progenitor cells and tumor-suppressive functions of
let-7. Cancer Res. 72:3393–3404. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xie K, Liu J, Zhu L, Liu Y, Pan Y, Wen J,
Ma H, Zhai X and Hu Z: A potentially functional polymorphism in the
promoter region of let-7 family is associated with survival of
hepatocellular carcinoma. Cancer Epidemiol. 37:998–1002. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kang L, Cui X, Zhang Y, Yang C and Jiang
Y: Identification of miRNAs associated with sexual maturity in
chicken ovary by Illumina small RNA deep sequencing. BMC Genomics.
14:3522013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Helland Å, Anglesio MS, George J, Cowin
PA, Johnstone CN, House CM, Sheppard KE, Etemadmoghadam D, Melnyk
N, Rustgi AK, et al: Deregulation of MYCN, LIN28B and LET7 in a
molecular subtype of aggressive high-grade serous ovarian cancers.
PLoS One. 6:e180642011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu X, Wu L, Yao J, Jiang H, Wang Q, Yang
Z and Wu F: MicroRNA let-7c inhibits cell proliferation and induces
cell cycle arrest by targeting CDC25A in human hepatocellular
carcinoma. PLoS One. 10:e01242662015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Broggini M, Buraggi G, Brenna A, Riva L,
Codegoni AM, Torri V, Lissoni AA, Mangioni C and D'Incalci M: Cell
cycle-related phosphatases CDC25A and B expression correlates with
survival in ovarian cancer patients. Anticancer Res. 20:4835–4840.
2000.PubMed/NCBI
|
|
18
|
Rodrigues S, Rodrigue CM, Attoub S, Fléjou
JF, Bruyneel E, Bracke M, Emami S and Gespach C: Induction of the
adenoma-carcinoma progression and Cdc25A-B phosphatases by the
trefoil factor TFF1 in human colon epithelial cells. Oncogene.
25:6628–6636. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nishioka K, Doki Y, Shiozaki H, Yamamoto
H, Tamura S, Yasuda T, Fujiwara Y, Yano M, Miyata H, Kishi K, et
al: Clinical significance of CDC25A and CDC25B expression in
squamous cell carcinomas of the oesophagus. Br J Cancer.
85:412–421. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Aref S, Fouda M, El-Dosoky E, Menessy A,
Mabed M, Saleeb M and Zalata K: c-Myc oncogene and Cdc25A cell
activating phosphatase expression in non-Hodgkin's lymphoma.
Hematology. 8:183–190. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Molinari M, Mercurio C, Dominguez J,
Goubin F and Draetta GF: Human Cdc25A inactivation in response to S
phase inhibition and its role in preventing premature mitosis. EMBO
Rep. 1:71–79. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pecorelli S: Revised FIGO staging for
carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol
Obstet. 105:103–104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Resnick KE, Alder H, Hagan JP, Richardson
DL, Croce CM and Cohn DE: The detection of differentially expressed
microRNAs from the serum of ovarian cancer patients using a novel
real-time PCR platform. Gynecol Oncol. 112:55–59. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Katz B, Tropé CG, Reich R and Davidson B:
MicroRNAs in ovarian cancer. Hum Pathol. 46:1245–1256. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Langhe R: microRNA and ovarian cancer. Adv
Exp Med Biol. 889:119–151. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang L, Volinia S, Bonome T, Calin GA,
Greshock J, Yang N, Liu CG, Giannakakis A, Alexiou P, Hasegawa K,
et al: Genomic and epigenetic alterations deregulate microRNA
expression in human epithelial ovarian cancer. Proc Natl Acad Sci
USA. 105:7004–7009. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Iorio MV, Visone R, Di Leva G, Donati V,
Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, et
al: MicroRNA signatures in human ovarian cancer. Cancer Res.
67:8699–8707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Han HB, Gu J, Zuo HJ, Chen ZG, Zhao W, Li
M, Ji DB, Lu YY and Zhang ZQ: Let-7c functions as a metastasis
suppressor by targeting MMP11 and PBX3 in colorectal cancer. J
Pathol. 226:544–555. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao B, Han H, Chen J, Zhang Z, Li S, Fang
F, Zheng Q, Ma Y, Zhang J, Wu N and Yang Y: MicroRNA let-7c
inhibits migration and invasion of human non-small cell lung cancer
by targeting ITGB3 and MAP4K3. Cancer Lett. 342:43–51. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang PY, Sun YX, Zhang S, Pang M, Zhang
HH, Gao SY, Zhang C, Lv CJ and Xie SY: Let-7c inhibits A549 cell
proliferation through oncogenic TRIB2 related factors. FEBS Lett.
587:2675–2681. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kristjánsdóttir K and Rudolph J: Cdc25
phosphatases and cancer. Chem Biol. 11:1043–1051. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu X, Yamamoto H, Sakon M, Yasui M, Ngan
CY, Fukunaga H, Morita T, Ogawa M, Nagano H, Nakamori S, et al:
Overexpression of CDC25Aphosphatase is associated with hypergrowth
activity and poor prognosis of human hepatocellular carcinomas.
Clin Cancer Res. 9:1764–1772. 2003.PubMed/NCBI
|
|
35
|
Blomberg I and Hoffmann I: Ectopic
expression of Cdc25A accelerates the G(1)/S transition and leads to
premature activation of cyclin E- and cyclin A-dependent kinases.
Mol Cell Biol. 19:6183–6194. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xiao Z, Chen Z, Gunasekera AH, Sowin TJ,
Rosenberg SH, Fesik S and Zhang H: Chk1 mediates S and G2 arrests
through Cdc25A degradation in response to DNA-damaging agents. J
Biol Chem. 278:21767–21773. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ray D and Kiyokawa H: CDC25A levels
determine the balance of proliferation and checkpoint response.
Cell Cycle. 6:3039–3042. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Guo R, Abdelmohsen K, Morin PJ and Gorospe
M: Novel MicroRNA reporter uncovers repression of Let-7 by GSK-3β.
PLoS One. 8:e663302013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhan M, Qu Q, Wang G, Liu YZ, Tan SL, Lou
XY, Yu J and Zhou HH: Let-7c inhibits NSCLC cell proliferation by
targeting HOXA1. Asian Pac J Cancer Prev. 14:387–392. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Donzelli M, Squatrito M, Ganoth D, Hershko
A, Pagano M and Draetta GF: Dual mode of degradation of Cdc25 A
phosphatase. EMBO J. 21:4875–4884. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ray D, Terao Y, Nimbalkar D, Chu LH,
Donzelli M, Tsutsui T, Zou X, Ghosh AK, Varga J, Draetta GF and
Kiyokawa H: Transforming growth factor beta facilitates
beta-TrCP-mediated degradation of Cdc25A in a Smad3-dependent
manner. Mol Cell Biol. 25:3338–3347. 2005. View Article : Google Scholar : PubMed/NCBI
|
